Source: The Market Herald

Acrux: Acrux (ASX:ACR) announces buyout of future Lenzetto royalties

Pharmaceutical company Acrux (ACR) has reached an agreement for the EUR 4.10...

Read full article »
Acrux's Competitors | Acrux's News | Acrux's Financials
Stay up-to-date with the latest news on Acrux
Annual Revenue
$100K-5.0M
Employees
25-100
Michael Kotsanis's photo - Managing Director & CEO of Acrux

Managing Director & CEO

Michael Kotsanis

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on Acrux